Trials / Recruiting
RecruitingNCT06084013
Use Of Indocyanine Green In Pancreas Surgery
Assessing the Role of Intraoperative Indocyanine Green Perfusion of the Transected Pancreas in Predicting Postoperative Pancreatic Leaks
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (estimated)
- Sponsor
- OHSU Knight Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the use of indocyanine green to predict postoperative pancreatic leaks in patients undergoing transection of the pancreas.
Detailed description
PRIMARY OBJECTIVE: I. To determine if altered measurement results of ICG after pancreatectomy is associated with leak rates. OUTLINE: This is an observational study. Patients receive indocyanine green intravenously (IV) during surgery, undergo imaging and have their medical records reviewed on study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional Study | Non-interventional study |
Timeline
- Start date
- 2024-05-17
- Primary completion
- 2025-12-31
- Completion
- 2026-02-28
- First posted
- 2023-10-16
- Last updated
- 2025-07-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06084013. Inclusion in this directory is not an endorsement.